Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19： a meta-analysis
W Wen, C Chen, J Tang, C Wang, M Zhou… - Annals of …, 2022 - Taylor & Francis
Background The coronavirus disease (COVID-19) epidemic has not been completely
controlled. Although great achievements have been made in COVID-19 research and many …
controlled. Although great achievements have been made in COVID-19 research and many …
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
Background The relationship between coronavirus disease 2019 (COVID-19) vaccination
and long COVID has not been firmly established. We conducted a systematic review and …
and long COVID has not been firmly established. We conducted a systematic review and …
[HTML][HTML] SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
S Pilz, V Theiler-Schwetz, C Trummer, R Krause… - Environmental …, 2022 - Elsevier
Seroprevalence surveys suggest that more than a third and possibly more than half of the
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
Conclusions SARS‐CoV‐2 vaccination can be associated with liver injury. Corticosteroid
therapy may be beneficial in those with immune‐mediated features or severe hepatitis …
therapy may be beneficial in those with immune‐mediated features or severe hepatitis …
[PDF][PDF] Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis.
OBJECTIVE: The outbreak of coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in the death of up to 5 …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in the death of up to 5 …
[HTML][HTML] Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America
Vaccine hesitancy, defined as the reluctance or rejection in receiving a vaccine despite its
availability, represents a major challenge to global health efforts aiming to control the …
availability, represents a major challenge to global health efforts aiming to control the …
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical …
F Hernández-Bernal, MC Ricardo-Cobas… - …, 2022 - thelancet.com
Background Multiple vaccine candidates against COVID-19 are currently being evaluated.
We evaluate the safety and immunogenicity protein of a novel SARS-CoV-2 virus receptor …
We evaluate the safety and immunogenicity protein of a novel SARS-CoV-2 virus receptor …
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
L Matarazzo, PJG Bettencourt - Frontiers in Immunology, 2023 - frontiersin.org
The success of the first licensed mRNA-based vaccines against COVID-19 has created a
widespread interest on mRNA technology for vaccinology. As expected, the number of …
widespread interest on mRNA technology for vaccinology. As expected, the number of …
Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review
Y Zhu, L Sharma, D Chang - Frontiers in Immunology, 2023 - frontiersin.org
An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …
has created a severe healthcare threat and become one of the biggest challenges to human …
mRNA vaccine development for emerging animal and zoonotic diseases
T Le, C Sun, J Chang, G Zhang, X Yin - Viruses, 2022 - mdpi.com
In the prevention and treatment of infectious diseases, mRNA vaccines hold great promise
because of their low risk of insertional mutagenesis, high potency, accelerated development …
because of their low risk of insertional mutagenesis, high potency, accelerated development …